Red cell distribution width, other hematological parameters and atherogenic index of plasma in patients with clopidogrel and aspirin resistance
Journal Title: The European Research Journal - Year 2016, Vol 2, Issue 3
Abstract
Objective. Chronic inflammation might favour platelet hyperactivity, which leads to inter-individual variability in antiplatelet resistance. The aim of this study was to test the hypothesis that there is a relationship between some hematological parameters reported as measures of systemic inflammation, the atherogenic index of plasma (AIP), and antiplatelet responsiveness. Methods. This retrospective study included patients receiving aspirin (100 mg) and clopidogrel (75 mg) daily before and after stenting. Platelet inhibition was assessed using the VerifyNow P2Y12 point-of-care test. Resistance to antiplatelet therapy was defined as P2Y12 reactivity exceeding 240 units (for clopidogrel) or aspirin reaction units exceeding 550 units (for aspirin). The AIP was calculated as the logarithm of triglyceride/high density lipoprotein cholesterol. The white blood cell (WBC), platelet (P), neutrophil (N), and lymphocyte (L) counts, red cell distribution width (RDW), hemoglobin (Hb), plateletcrit, mean platelet volume (MPV), platelet distribution width, and N/L and P/L ratios were evaluated. Results. Of 232 patients (73% male; median age, 63 years; range, 38-87 years), 52 (22%) were aspirin resistant and 82 (35%) were clopidogrel resistant; 7.7% were both aspirin and clopidogrel resistant. Median RDW levels were significantly higher (14.4% [interquartile range (IQR) 3] vs. 13.9% [IQR 1.3]; p=0.01) and Hb levels significantly lower (12.0±1.6 g/dL vs. 13.2±1.7 g/dL; p<0.001) in the clopidogrel-resistant patients than in the clopidogrel responders. WBC, AIP, MPV, N/L, and P/L ratios were not statistically significant (p>0.05). Multivariate logistic regression showed that Hb (odds ratio [OR]=0.73; 95% confidence interval [CI], 0.60-0.88; p=0.001) and RDW (OR=1.26; 95% CI, 1.02-1.55; p=0.02) were independent predictors of clopidogrel resistance. Conclusion. Both RDW and Hb were independent variables associated with clopidogrel resistance, but antiplatelet resistance cannot be predicted based on other hematological parameters or AIP.
Authors and Affiliations
Yasemin Ustundag Budak, Kagan Huysal, Sanem Karadag Gecgel, Hasan Ari, Mehmet Melek, Senol Yavuz, Sencer Camci, Alper Karakus, Ibrahim Aktas, Selma Ari
Keywords
Related Articles
- EP ID EP183086
- DOI 10.18621/eurj.2016.5000200132
- Views 218
- Downloads 0
Adrenal hemorrhage in the neonatal intensive care unit: a four-year experience
Objectives: Adrenal hemorrhage is relatively uncommon and usually underestimated. This study aimed to review the clinical, predisposing factors and ultrasonographic findings of adrenal hemorrhage newborns treated in hosp...
Correlation of serum C-reactive protein and procalcitonin levels in infections of kidney transplant recipients
Objectives. Procalcitonin is a propeptide of calcitonin and has been increasingly used as a biomarker of infection. The aim of this study was to evaluate correlation of serum C-reactive protein (CRP) and procalcitonin (P...
Physician versus the smoking habit of the patient
Objective. This study has aimed to investigate the bases, conditions and the characteristics of the counselling approach of physicians serving in diverse branches of medicine in our hospital. Methods. Volunteering physic...
Importance of preoperative hematological parameters in patients undergoing surgical resection for colorectal cancer
Objectives. Colorectal cancer has a high prevalence worldwide, and new predictive and prognostic factors are needed for its early diagnosis, treatment, and follow-up. In this study, we have investigated the relationship...
The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome
Objective. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting up to 10% of reproductive-age women. Anti-Mullerian hormone (AMH) is a member of the transforming growth factor β famil...